BioCentury
ARTICLE | Clinical News

Valrubicin cream: Phase IIa started

March 15, 2010 7:00 AM UTC

Valderm began a double-blind, placebo-controlled, international Phase IIa trial to compare 2 strengths of valrubicin cream applied once daily under occlusion vs. calcipotriol and betamethasone valerat...